Carglumic Acid - CAS 1188-38-1

Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.

Others

Others

1149

0.998

C6H10N2O5

190.15

[C@@H](CCC(O)=O)(NC(N)=O)C(O)=O

-20°C

Ice Packs

Small Compound